血氧水平依赖磁共振成像测量肾组织氧合:声明与系统综述
本文系统综述了BOLD-MRI测量肾组织氧合的研究,指出R2*升高提示氧合降低,已在动物中验证,人体可重复。CKD或严重肾动脉狭窄患者肾组织氧合低于对照,CKD患者皮质氧合最低者肾脏结局最差。文章还就患者准备、图像采集与分析提出推荐,并呼吁通过PARENCHIMA等行动 harmonize 流程。
要点
- BOLD-MRI通过R2*反映肾组织脱氧血红蛋白水平,R2*升高提示氧合降低。
- CKD或严重肾动脉狭窄患者肾组织氧合低于对照,CKD皮质氧合最低者肾脏结局最差。
- BOLD-MRI可用于早期评估药物对肾组织氧合的影响,识别肾保护或肾毒性药物。
核心结论
- BOLD-MRI是监测人肾组织氧合最有前景的影像技术,但需标准化生理和技术条件以保证可重复性。
研究设计与样本
- 本文为声明与系统综述,基于动物微穿刺验证和人体可重复性研究,总结BOLD-MRI在肾脏病中的应用。
主要发现
- BOLD-MRI的R2*升高对应脱氧血红蛋白浓度增高,提示氧合降低;R2*降低提示氧合升高。
- CKD或严重肾动脉狭窄患者肾组织氧合低于对照,CKD患者皮质氧合最低者肾脏结局最差。
- BOLD-MRI已用于评估药物对肾组织氧合的影响,可能早期识别肾保护或肾毒性药物。
关键数值与推荐
- BOLD-MRI的结局指标为R2*(横向弛豫率,单位每秒),其升高提示氧合降低,降低提示氧合升高。
- 人体可重复性已在标准化生理和技术条件下得到证实。
临床怎么用
- 临床可应用BOLD-MRI评估CKD或肾动脉狭窄患者的肾组织氧合,但需遵循标准化患者准备、图像采集和分析流程。
局限性
- 目前患者准备、MRI数据采集和BOLD图像分析方法不统一,需国际 harmonization 以推动临床常规应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tissue hypoxia plays a key role in the development and progression of many kidney diseases. Blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) is the most promising imaging technique to monitor renal tissue oxygenation in humans. BOLD-MRI measures renal tissue deoxyhaemoglobin levels voxel by voxel. Increases in its outcome measure R2* (transverse relaxation rate expressed as per second) correspond to higher deoxyhaemoglobin concentrations and suggest lower oxygenation, whereas decreases in R2* indicate higher oxygenation. BOLD-MRI has been validated against micropuncture techniques in animals. Its reproducibility has been demonstrated in humans, provided that physiological and technical conditions are standardized. BOLD-MRI has shown that patients suffering from chronic kidney disease (CKD) or kidneys with severe renal artery stenosis have lower tissue oxygenation than controls. Additionally, CKD patients with the lowest cortical oxygenation have the worst renal outcome. Finally, BOLD-MRI has been used to assess the influence of drugs on renal tissue oxygenation, and may offer the possibility to identify drugs with nephroprotective or nephrotoxic effects at an early stage. Unfortunately, different methods are used to prepare patients, acquire MRI data and analyse the BOLD images. International efforts such as the European Cooperation in Science and Technology (COST) action 'Magnetic Resonance Imaging Biomarkers for Chronic Kidney Disease' (PARENCHIMA) are aiming to harmonize this process, to facilitate the introduction of this technique in clinical practice in the near future. This article represents an extensive overview of the studies performed in this field, summarizes the strengths and weaknesses of the technique, provides recommendations about patient preparation, image acquisition and analysis, and suggests clinical applications and future developments.
引用
- Pruijm M, Mendichovszky IA, Liss P, et al. Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review. Nephrol Dial Transplant. 2018. PMID: 30137579. doi:10.1093/ndt/gfy243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。